The FDA issues a safety alert regarding the use of hydroxychloroquine outside of hospital settings or clinical trials. Dr. Zelenko and the hosts discuss the obstacles to adopting low-cost, out-of-patent treatments, citing medical ego, fear of liability, and the financial interests of large pharmaceutical companies. They argue that the industry prefers expensive new vaccines over cheap, existing solutions.
